Immunologix, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Immunologix, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					                  Immunologix, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances
                                                 Profile
       Reference Code: GDPH243686D                                                                                                              Publication Date: SEP 2012

      Company Overview                                                                                         Key Facts
      Immunologix, Inc. (Immunologix) is an antibody development company, engaged in                           Immunologix, Inc., Pharmaceuticals & Healthcare,
      the development of antibody-based therapeutics. The founding principal of the                            Key Facts
      company is towards developing a proprietary method of converting naïve B-cells to
                                                                                                                Web Address                          NA
      fully mature human antibodies targeting any antigen. Its proprietary technology
      platform, mAbLogix, enables Immunologix to generate human antibodies using a                              Revenue (US$ million)                              NA
      100% in vitro system with optimal safety profile. The mAbLogix system generates                           Number of Employees                                NA
      human monoclonal antibodies against bacterial antigens, tumor antigens, viral
                                                                                                                GlobalData
      antigens and human auto-antigens. The company is headquartered in Charleston,
      South Carolina, the US.

      Financial Deals Landscape
        Immunologix, Inc., Pharmaceuticals & Healthcare, Deals by                          Immunologix, Inc., Pharmaceuticals & Healthcare, Deals By
        Type, 2006 to YTD 2012                                                             Year, 2006 to YTD 2012


                                                                                                                                                             2
                                                                                                           2




                                                                                            No. of Deals
                                                                                                                                                     1
                                                                                                           1


                                                                                                                  0          0       0      0                         0
                                                                                                           0
                                                                                                                2006        2007   2008    2009     2010    2011     YTD
                                                                                                                                                                     2012

                                                                                           Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from         from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Immunologix, Inc., Pharmaceuticals & Healthcare, Deals By                         Immunologix, Inc., Pharmaceuticals & Healthcare, Deals By
         Region, 2006 to YTD 2012                                                          Therapy Area, 2006 to YTD 2012


                         3                                                                                                   2              2
          No. of Deals




                                    3                                                                      2
                                                                                            No. of Deals




                         2
                                                 1            1          1            1                                                                      1
                         1                                                                                 1

                         0
                              North            Asia-     Europe        Middle    South
                              Americ           Pacific                  East      and                      0
                                a                                       and      Central                                Infectious       Oncology          Central
                                                                       Africa    Americ                                  Disease                           Nervous
                                                                                   a                                                                       System


         Note: Deals include all announced pharmaceuticals & healthcare deals              Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                     from 2006 onwards, GlobalData



         Immunologix, Inc., Pharmaceuticals & Healthcare, Licensing                        Immunologix, Inc., Pharmaceuticals & Healthcare, Licensing
         Deals by Year, 2006 to YTD 2012                                                   Deals by Phase, 2006 to YTD 2012


                                                                   1
                                                                                                      Discovery                                                           1
                         1
                                                                                                       Marketed         0
          No. of Deals




                                                                                                      Approved          0
                                                                                                       Phase IV         0
                                                                                                        Phase III       0
                                                                                                        Phase II        0
                                                                                                         Phase I        0
                                                                                                     Pre Clinical       0
                              0          0        0       0                  0    0
                         0
                             2006       2007    2008     2009     2010   2011    YTD                                0                                                1
                                                                                 2012
                                                                                                                                          No. of Deals
         Note: Deals include all announced pharmaceuticals & healthcare deals              Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                     from 2006 onwards, GlobalData


Immunologix, Inc. - Pharmaceuticals & Healthcare - Deals and                                                                                      Reference Code: GDPH243686D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                    Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Immunologix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 ..................................................................... 4
       Immunologix, Inc., Pharmaceuticals & Healthcare Deals By Type, 2006 to YTD 2012 ...................................................................... 5
       Immunologix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012 .................................................................. 6
       Immunologix, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2006 to YTD 2012 ....................................................... 7
       Immunologix, Inc., Pharmaceuticals & Healthcare, Medical Devices Deals, 2006 to YTD 2012 ........................................................ 8
       Immunologix, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to
       YTD 2012 ........................................................................................................................................................................................... 9
       Immunologix, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Phase Vs Deal Value Vs Upfront Payment, 2006 to
       YTD 2012 ......................................................................................................................................................................................... 10
       Immunologix, Inc., Pharmaceuticals & Healthca
				
DOCUMENT INFO
Description: Immunologix, Inc. (Immunologix) is an antibody development company, engaged in the development of antibody-based therapeutics. The founding principal of the company is towards developing a proprietary method of converting naïve B-cells to fully mature human antibodies targeting any antigen. Its proprietary technology platform, mAbLogix, enables Immunologix to generate human antibodies using a 100% in vitro system with optimal safety profile. The mAbLogix system generates human monoclonal antibodies against bacterial antigens, tumor antigens, viral antigens and human auto-antigens. The company is headquartered in Charleston, South Carolina, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.